Antares Pharma, Inc. (ATRS)

[cacheflash57]

The die has been cast for the epipen. Was watching a segment on cnbc and the talking heads were saying that they buy epipens for their kids. Mylans claim that 80% of people with insurance, using their savings card get the pen for nothing. Their response was they have pretty darn good insurance with cnbc and none of them had ever gotten their epipens for 0 copay. I think this new savings card is some of the same smoke and mirrors and it will still only be good for one pair. Most people have to buy two or three, but this does not matter the die is cast, too much outrage, with the govt getting involved now. This will not end good for mylan, saw also on cnbc that 5 senators had written a letter to the fda asking why the teva generic had not been approved. Does not matter what mylan does now, their will be a hearing and want to know the whole story on the generic. An analyst was talking about mylans citizen petition and their lobbying congress, along with their insistance on sameness. Hope teva gives the senators the study done by American College of Allergists that found that people owning epipens did not know how to use them after 3 months if they have not used the pen. Think they said they needed to be retrained. Was that not mylans argument against the generic, that they would have to be trained?